← Previous Page
...
Biopharma

Research Reproducibility: The Hidden Limiter of AI in Biopharma Labs

Ellen Ovenden, MSc & Rucha Joshi, MSc | Mar 31, 2026
Ellen Ovenden, MSc & Rucha Joshi, MSc | Mar 31 2026

AI in research is now embedded across target discovery, compound screening, image analysis, omics integration, and trial design.

Today, AI is already shaping multiple stages of drug discovery and development, from early modeling to clinical decision support.1 But even the most advanced models still depend on one basic input: reliable experimental data.

That matters because AI can only scale what the lab produces. If methods are not repeatable, visual, and standardized, models become harder to trust across studies, sites, and partners.

In biopharma, research reproducibility is still the foundation for scale.

How AI Raises the Stakes on Reproducibility

AI is already helping teams process larger, more complex datasets and move faster from data collection to decisions. But as data volume and model complexity increase, small differences in execution can propagate into unreliable signals.

This is especially important in AI-enabled biopharma R&D workflows, where high-quality inputs determine whether models can generalize across studies and sites.

To explore this in more detail, register for our upcoming webinar AI, Visualization, and the Next Era of Biopharma R&D.

The 3Rs in Action (1)

 

The Reproducibility Gap Underlying AI Initiatives

This is where the broader problem of reproducibility in life science research becomes important. A 2024 survey of 1,630 biomedical researchers found that 72% believe biomedicine faces a reproducibility crisis, while only 16% said their institution has procedures in place to improve it.2

In real labs, these experimental reproducibility challenges show up as inconsistent SOP interpretation, tacit technique steps, and variable training across shifts or sites.

For AI, noisy experimental execution leads to one thing: noisy data. Inconclusive data not only indicates weakness in research reproducibility but reliability in AI models as a whole.

In a time of increased scientific uncertainty, ensuring your AI models are built on reproducible experimental data is essential to trust, scale, and defensibility.

What Biopharma Leaders Can Do Now

For teams asking how to improve research reproducibility in labs while building AI-ready workflows, the practical starting point is still at the bench:

  • ▪️ Audit variability across assays, sites, and shifts by identifying where execution drift is highest, especially in workflows that produce data for AI models and downstream decision making.
  • ▪️ Prioritize critical methods for standardizing lab procedures in biopharma, especially where data feeds modeling, validation, or decision support.
  • ▪️ Use visual method references such as scientific video protocols to clarify tacit steps and support training for biopharma scientists on high-risk methods.
  • ▪️ Adopt refreshable, centralized scientific training content tied to lab performance metrics, supporting multisite alignment and reducing R&D variability for AI-ready data.

A recent systematic review found that video-based approaches improved learning outcomes in health education, especially where practical skills were involved.3 In biopharma, that makes visual training a practical tool for best practices for consistent experimental results and biopharma R&D operational risk reduction.

AI can accelerate R&D. But repeatable, visual, and standardized experimental execution is still the foundation for trust and scale.

Explore how JoVE supports scientific training solutions for reproducible, AI-ready biopharma R&D.

  1. Zhang, Y., Mastouri, M., & Zhang, Y. (2024). Accelerating drug discovery, development, and clinical trials by artificial intelligence. Med, 5(10), 1386–1404. https://doi.org/10.1016/j.medj.2024.07.026 
  2. Cobey, K. D., Ebrahimzadeh, S., Page, M. J., et al. (2024). Biomedical researchers’ perspectives on the reproducibility of research. PLOS Biology, 22(11), e3002870. https://doi.org/10.1371/journal.pbio.3002870 
  3. Morgado, M., Botelho, J., Machado, V., et al (2024). Video-based approaches in health education: A systematic review and meta-analysis. Scientific Reports, 14, 23651. https://doi.org/10.1038/s41598-024-73671-7 

Related Posts